| Bioactivity | VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI (TFA) is the 13C and 15N labeled isotope of VQPGQN-HMFTKEKLEEVIKDI (TFA)[1]. |
| Sequence | Val-Gln-Pro-Gly-Gln-Asn-{Phe-13C9,15N}-His-Met-Phe-Thr-Lys-Glu-Lys-Leu-Glu-Glu-Val-Ile-Lys-Asp-Ile |
| Shortening | VQPGQN-{Phe-13C9,15N}-HMFTKEKLEEVIKDI |
| Formula | C11013C9H188N2915NO35S.xC2HF3O2 |
| Molar Mass | 2640.94 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak, et sl. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals. Annals of Pharmacotherapy 53.2 (2019): 211-223. |
VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA
CAS: F: C11013C9H188N2915NO35S.xC2HF3O2 W: 2640.94 (free acid)
VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI (TFA) is the 13C and 15N labeled isotope of VQPGQN-HMFTKEKLEEVIKDI (TFA).
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.